Skip to main content

LIVE

HKPD

Cellyan Biotechnology Co., Ltd

HKPD

NASDAQ·Healthcare·Medical - Distribution·Mkt cap $1.4M

$0.13

-8.86%

P/E

Mkt Cap

$1.4M

52-Wk Range

$0.12–$1.82

52-Week Range

$0.12 - $1.82

P/E

Fwd P/E

Beta

2.23

Div Yield

0.00%

Avg Vol

1.9M

Shares Out

11.0M

Mkt Cap

$1.4M

Price action

Price chart

Down 89.5% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Cross-border pharmaceutical expertise and regulatory compliance capabilities
  • Integrated supply chain infrastructure reducing logistics costs
  • Strategic positioning in high-growth Hong Kong-China pharmaceutical corridor
  • Digital-first e-commerce distribution model aligned with market trends

Bear Case

1 risk

  • High volatility (beta 2.2). Larger-than-normal price swings expected.

Growth

No forward estimates available

Explosive growth in OTC pharmaceutical e-commerce across Asia

Value

Valuation data unavailable

Momentum

Falling

-73.9% over 3m

Quality

Thin

Solid business

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

LATEST RECAP

Most recent quarter reported revenue of $1.2M (-5% YoY). Reported EPS of -$0.01. Gross margin 5.5%.

Reported EPS · last 4Q

Q4 25

-$0.01

Q2 24

$0.01

Q4 24

$0.01

Q2 23

$0.00

Revenue trend · last 4Q

+58%

-5%

Q2 23

Q4 24

Q2 24

Q4 25

$894.4K

$1.2M

$1.4M

$1.2M

Margins · last 4Q

Gross

5.5%

Operating

-9.7%

Profit

-9.3%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

vs Industry

How HKPD stacks vs Medical - Distribution

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.